Epidemiology of osteochimionecrosis of the jaws in France, update of data since 2015

•The incidence of osteochimionecrosis of the jaws appears to be increasing.•Since 2015 bisphosphonates are not any longer the main causing drugs.•Since 2015 Denosumab became the main causing drug.•More than one third of the cases were due to non-oncological drug prescriptions.

Saved in:

Bibliographic Details
Published in:	Journal of stomatology, oral and maxillofacial surgery Vol. 123; no. 5; pp. e448 - e453
Main Authors:	Legendre, Q, Faillie, Jl, Lapeyrie, P, Tramini, P, Maladiere, E, Torres, JH, Lallemant, B
Format:	Journal Article
Language:	English
Published:	France Elsevier Masson SAS 01-10-2022 Elsevier Masson
Subjects:	Adverse drug reaction Bisphosphonates Denosumab Human health and pathology Life Sciences Osteochimionecrosis Osteonecrosis of the jaw Pharmacovigilance Osteochimionecrosis Pharmacovigilance Adverse drug reaction Denosumab Bisphosphonates Osteonecrosis of the jaw
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	•The incidence of osteochimionecrosis of the jaws appears to be increasing.•Since 2015 bisphosphonates are not any longer the main causing drugs.•Since 2015 Denosumab became the main causing drug.•More than one third of the cases were due to non-oncological drug prescriptions.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2468-7855 2468-7855
DOI:	10.1016/j.jormas.2021.12.015